When a radiologist's RADAR goes off

Article

While physicians apologizing to patients for mistakes is good medicine, the best scenario is one in which errors don't occur. Researchers have developed various software programs linked to the radiologist's report that "red flag" significant findings and automatically generate communication to the referring physician.

While physicians apologizing to patients for mistakes is good medicine, the best scenario is one in which errors don't occur. Researchers have developed various software programs linked to the radiologist's report that "red flag" significant findings and automatically generate communication to the referring physician.

One such program is called RADAR, for Radiology Alert and Data Accrual Registry. Developed by Dr. Richard Chesbrough, director of the mortality/morbidity legal course at Henry Ford Hospital in Detroit, the program will automatically notify referring physicians when the radiologist dictates "RADAR alert, important finding" at the end of the report. It will also document the process in the final report.

If a patient has experienced some complication associated with his or her imaging exam, such as IV contrast reaction, pain, or even the perception of rude treatment, the radiologist simply dictates "RADAR-risk management" at the end of the report. The program will send a copy of the report to risk management and the department chair.

"This type of program helps hospital administration move quickly to take corrective action and avert a potential legal liability," Chesbrough said. "Often, an apology and explanation to the patient and/or family is all that is needed. In other cases, the hospital will want to work with the patient to void certain medical bills. The hospital and legal department may offer a small monetary remedy to the injured patient, to avoid more costly litigation later." -CPK

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.